Reproductive endocrinology

Hepatic metabolism of 11-oxygenated androgens in humans: an integrated in vivo and ex vivo approach

Eur J EndocrinolPublished Mechanistic study

Authors' conclusion

Using in vivo and ex vivo approaches, we report the predominance of 11β-hydroxy metabolites, highlighting the pivotal role of hepatic 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) activity in 11-oxygenated androgen metabolism. We identify 11KAn as the only metabolite without overlap with glucocorticoid metabolism, underscoring its specificity and biomarker potential. NMLP represents a novel integrated model to study human hepatic steroid metabolism.

Study context

Population
Women with PCOS (in vivo); human liver tissue explants and whole human livers in normothermic machine liver perfusion (NMLP) (ex vivo)human liver tissue explants 3 · whole human livers in NMLP 3
Participants
10 vs 10
Comparison
Oral DHEA vs oral 11-ketoandrostenedione, 150 mg for 7 days
  • Oral dehydroepiandrosteronen = 10
  • 11KA4n = 10
Outcome
Hepatic 11-oxygenated androgen metabolism
Methodological detailsrandomised oral androgen challenge, ex vivo normothermic machine liver perfusion (NMLP), human liver tissue explants, 24-hour urine multi-steroid profiling by liquid chromatography-tandem mass spectrometry pre- and post-intervention
  • Randomised oral androgen challenge
  • Ex vivo normothermic machine liver perfusion (NMLP)
  • Human liver tissue explants
  • 24-hour urine multi-steroid profiling by liquid chromatography-tandem mass spectrometry pre- and post-intervention

Main finding

As reported in the abstract

  • Ex vivo: main metabolites were 11β-hydroxyandrosterone and 11β-hydroxyetiocholanolone
  • In vivo oral 11KA4: significant increases in urinary 11β-hydroxyandrosterone, 11β-hydroxyetiocholanolone and 11-ketoetiocholanolone, all overlapping with glucocorticoid metabolism
  • Significant increases in urinary 11-ketoandrosterone (11KAn) excretion

Original publication

Hepatic metabolism of 11-oxygenated androgens in humans: an integrated in vivo and ex vivo approach. Eur J Endocrinol. Published 8 August 2025. doi:10.1093/ejendo/lvaf166

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.